|
1
|
Fisher C: Synovial sarcoma. Ann Diagn
Pathol. 2:401–421. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark J, Rocques PJ, Crew AJ, Gill S,
Shipley J, Chan AM, Gusterson BA and Cooper CS: Identification of
novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2)
translocation found in human synovial sarcoma. Nat Genet.
7:502–508. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corey RM, Swett K and Ward WG:
Epidemiology and survivorship of soft tissue sarcomas in adults: A
national cancer database report. Cancer Med. 3:1404–1415. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spillane AJ, A'Hern R, Judson IR, Fisher C
and Thomas JM: Synovial sarcoma: A clinicopathologic, staging, and
prognostic assessment. J Clin Oncol. 18:3794–3803. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vlenterie M, Ho VK, Kaal SE, Vlenterie R,
Haas R and van der Graaf WT: Age as an independent prognostic
factor for survival of localized synovial sarcoma patients. Br J
Cancer. 113:1602–1606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang S, Song R, Sun T, Hou B, Hong G,
Mallampati S, Sun H, Zhou X, Zhou C, Zhang H, et al: Survival
changes in patients with synovial sarcoma, 1983–2012. J Cancer.
8:1759–1768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deshmukh R, Mankin HJ and Singer S:
Synovial sarcoma: The importance of size and location for survival.
Clin Orthop Relat Res. 419:155–161. 2004. View Article : Google Scholar
|
|
8
|
Pan M and Merchant M: Risk factors
including age, stage and anatomic location that impact the outcomes
of patients with synovial sarcoma. Med Sci (Basel).
6:E212018.PubMed/NCBI
|
|
9
|
Chan GS, Yuen ST and Chan KW: Synovial
sarcoma presenting as a polypoid jejunal mass. Histopathology.
44:191–193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alsharief AN, Fageeh M and Alabdulkarim Y:
Monophasic synovial sarcoma presenting as a primary ileal mass: A
case report and review of the literature. J Med Case Reports.
6:832012. View Article : Google Scholar
|
|
11
|
Parfitt JR, Xu J, Kontozoglou T, Oluwafemi
AR and Driman DK: Primary monophasic synovial sarcoma of the colon.
Histopathology. 50:521–523. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Desar IME, Fleuren EDG and van der Graaf
WTA: Systemic treatment for adults with synovial sarcoma. Curr
Treat Options Oncol. 19:132018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krieg AH, Hefti F, Speth BM, Jundt G,
Guillou L, Exner UG, von Hochstetter AR, Cserhati MD, Fuchs B,
Mouhsine E, et al: Synovial sarcomas usually metastasize after
>5 years: A multicenter retrospective analysis with minimum
follow-up of 10 years for survivors. Ann Oncol. 22:458–467. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Butori C, Hofman V, Attias R, Mouroux J,
Pedeutour F and Hofman P: Diagnosis of primary esophageal synovial
sarcoma by demonstration of t(X;18) translocation: A case report.
Virchows Arch. 449:262–267. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vlenterie M, Litière S, Rizzo E, Marréaud
S, Judson I, Gelderblom H, Le Cesne A, Wardelmann E, Messiou C,
Gronchi A, et al: Outcome of chemotherapy in advanced synovial
sarcoma patients: Review of 15 clinical trials from the European
Organisation for Research and Treatment of Cancer Soft Tissue and
Bone Sarcoma Group; setting a new landmark for studies in this
entity. Eur J Cancer. 58:62–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Judson I, Verweij J, Gelderblom H,
Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan
J, Hohenberger P, et al: European Organisation and Treatment of
Cancer Soft Tissue and Bone Sarcoma Group: Doxorubicin alone versus
intensified doxorubicin plus ifosfamide for first-line treatment of
advanced or metastatic soft-tissue sarcoma: A randomised controlled
phase 3 trial. Lancet Oncol. 15:415–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
